Overview

Aliskiren and Muscle Sympathetic Nerve Activity

Status:
Unknown status
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The central hypothesis of this project is that Aliskiren causes a substantial decrease in MSNA in hypertensive patients with CKD.
Phase:
Phase 4
Details
Lead Sponsor:
UMC Utrecht